The status and progress of first-line treatment against Helicobacter pylori infection: a review
The status and progress of first-line treatment against Helicobacter pylori infection: a review
About this item
Full title
Author / Creator
Liu, Caiqi , Wang, Yuan , Shi, Jiaqi , Zhang, Chunhui , Nie, Jianhua , Li, Shun and Zheng, Tongsen
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Helicobacter pylori (HP) is a major causative agent of chronic gastritis and peptic ulcer. HP is also engaged in the development of gastric cancer and gastric mucosa-associated lymphoid tissue lymphoma. It is an important pathogenic factor in various other systemic diseases, such as vitamin B12 deficiency, iron deficiency, and idiopathic thrombocyt...
Alternative Titles
Full title
The status and progress of first-line treatment against Helicobacter pylori infection: a review
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8243100
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8243100
Other Identifiers
ISSN
1756-2848,1756-283X
E-ISSN
1756-2848
DOI
10.1177/1756284821989177
